The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury
Key result
COVID-19-related myocardial injury can lead to long-term structural and functional changes, including persistent myocardial fibrosis, reduced ejection fraction, and new-onset arrhythmias.
Population
Patients with COVID-19 cardiac involvement
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
COVID-19 myocardial injury may cause lasting fibrosis, thrombi, and LV enlargement; leaves open need for targeted surveillance trials.
Key Points
- This research aims to understand the mechanisms behind COVID-19-related cardiac injury and its long-term effects.
- Examined direct viral invasion and indirect injuries (hypercoagulability, immune-mediated) in cardiac patients.
- Identified structural changes including myocardial fibrosis and reduced ejection fraction.
- Utilized prospective data from biobanks to analyze findings.
- Patients exhibited persistent myocardial fibrosis and enlarged left ventricle with reduced ejection fraction (less than normal ranges).
- Reported an increased occurrence of intraventricular thrombi and new-onset arrhythmias among affected individuals.
- Observations indicate poor clinical outcomes linked to COVID-19 cardiac involvement.
Structured PICO
P
Population
Patients with COVID-19 cardiac involvement
COVID-19 can cause both direct and indirect myocardial injury, potentially leading to long-term structural and functional cardiac consequences.
Limitations
- Current findings are based on preliminary data and require larger prospective studies for validation.
Cite This Study
Siripanthong et al. (2022) conducted a review in COVID-19-related myocardial injury. COVID-19 was evaluated. COVID-19-related myocardial injury can lead to long-term structural and functional changes, including persistent myocardial fibrosis, reduced ejection fraction, and new-onset arrhythmias.